Sounds good but:

Dr. Alberto Espay, a neurologist at the University of Cincinnati College of Medicine, said that the 27% slowing in the progression of the illness falls below the threshold of what would be "noticeable" to a patient.

“The odds for brain swelling and hemorrhage are far higher than any actual improvement,” said Espay, who launched a petition in June calling for the Alzheimer’s treatment to not get full approval.